Targeting Cirrhosis & Fibrotic Complications To Improve Translational Relevance, Enable Late-Stage Intervention & Expand Therapeutic Impact In Mash
- Targeting cirrhotic progression and fibrotic complications to improve translational understanding of advanced disease, enabling more clinically relevant therapeutic development
- Developing preclinical strategies focused on cirrhosis-associated pathways to improve intervention opportunities, strengthening late-stage treatment potential and translational applicability
- Expanding therapeutic focus beyond early fibrosis to address advanced MASH populations, improving long-term clinical impact and future treatment opportunities